Paper3155687
Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule.
Frade R and 6 others. Eur J Immunol, 1985. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Papers, record 3155687. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3155687
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| B-Lymphocytes | Major topic |
| Immunoglobulin G | Major topic |
| Lymphocyte Activation | Major topic |
| Receptors, Complement | Major topic |
| Animals | |
| Growth Substances | |
| Humans | |
| Immune Tolerance | |
| Immunoglobulin Fab Fragments | |
| Interleukin-4 | |
| Lymphokines | |
| Molecular Weight | |
| Rabbits | |
| Receptors, Complement 3d |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33868238 | Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells. | Front Immunol | 2021 | https://conductscience.org/library/papers/33868238 | PubMed |
| 11043778 | Regulation of humoral immune responses by CD21/CD35. | Immunol Rev | 2000 | https://conductscience.org/library/papers/11043778 | PubMed |
| 8348744 | Determination of soluble CD21 as a parameter of B cell activation. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8348744 | PubMed |
| 3500472 | Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3500472 | PubMed |
| 3487090 | Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3487090 | PubMed |
| 3485654 | The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation. | J Clin Immunol | 1986 | https://conductscience.org/library/papers/3485654 | PubMed |
| 3484510 | Tissue-specific phosphorylation of complement receptors CR1 and CR2. | J Exp Med | 1986 | https://conductscience.org/library/papers/3484510 | PubMed |
| 3110330 | Surface antigens associated with human B cell activation. | Immunol Res | 1986 | https://conductscience.org/library/papers/3110330 | PubMed |
| 3027404 | Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor. | J Virol | 1987 | https://conductscience.org/library/papers/3027404 | PubMed |
| 3016712 | Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3016712 | PubMed |
| 2983347 | gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/2983347 | PubMed |
| 2960763 | CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review. | Immunol Res | 1987 | https://conductscience.org/library/papers/2960763 | PubMed |
| 2949381 | Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/2949381 | PubMed |
| 2943542 | Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/2943542 | PubMed |
| 2832506 | Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. | J Exp Med | 1988 | https://conductscience.org/library/papers/2832506 | PubMed |
| 2827171 | Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2827171 | PubMed |
| 2825176 | Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2825176 | PubMed |
| 2557614 | Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2557614 | PubMed |
| 2521478 | C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. | Infect Immun | 1989 | https://conductscience.org/library/papers/2521478 | PubMed |
| 2461345 | Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. | Immunology | 1988 | https://conductscience.org/library/papers/2461345 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FANCB | 2187 | PubTator's text mining | https://conductscience.org/library/genes/2187 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3155687
GET https://conductscience.org/api/papers/v1/3155687/cited_by?page=2